Agilent Technologies surpasses earnings expectations and lifts full-year forecast, offsetting weakness in China and other key markets.
Agilent Technologies (NYSE:A) reported stronger-than-expected earnings, with both top and bottom lines beating estimates. The company also raised its full-year guidance, driving a 17% stock surge, though shares remain flat year-to-date.
Despite softness in China, food, academic, and government spending, growth in drug development, diagnostics, and semiconductor testing offset the declines. The company will present new product data at an upcoming industry conference.
Agilent provides instruments and services for life sciences, diagnostics, and chemical analysis, serving sectors like genomics and lab automation.